Gyre Therapeutics (GYRE) Dividends Paid - Common (2023)
Gyre Therapeutics (GYRE) reported Dividends Paid - Common of $1.5 million for Q3 2023, down 57.14% on a QoQ basis from $3.5 million in Q2 2023.
Gyre Therapeutics (GYRE) has 1 years of Dividends Paid - Common data on file, last reported at $1.5 million in Q3 2023.
- Quarterly Dividends Paid - Common changed N/A year-over-year to $1.5 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $12.8 million (changed N/A YoY) and the FY2022 annual result came in at $45.0 million, changed N/A from the prior year.
- Dividends Paid - Common fell to $1.5 million in Q3 2023 per GYRE's latest filing, from $3.5 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $7.8 million in Q1 2023 and bottomed at $1.5 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 97.80 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 7.76 Mn |
| Mar 31, 2023 | 7.76 Mn |